Safety of nilotinib in patients with acute myeloid leukaemia: A retrospective study

Trial Profile

Safety of nilotinib in patients with acute myeloid leukaemia: A retrospective study

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Nilotinib (Primary) ; Cytarabine
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Aug 2016 New trial record
    • 07 Jun 2016 Primary endpoint of heart failure has not been met, according to results presented at the at the 52nd Annual Meeting of the American Society of Clinical Oncology.
    • 07 Jun 2016 Results presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top